This clinical trial is focused on studying the effects of a medication called Rocuronium bromide in infants undergoing surgery for a condition known as craniosynostosis. Craniosynostosis is a condition where the bones in a baby’s skull join together too early, which can affect the shape of the head and brain development. The medication, Rocuronium bromide, is used to help relax muscles during surgery, making it easier for doctors to perform the procedure.
The purpose of the study is to understand how different doses of Rocuronium bromide work in infants, especially when used alongside two types of anesthesia: sevoflurane, which is inhaled, and propofol, which is given through an IV. Anesthesia is used to keep patients asleep and pain-free during surgery. The study aims to see how these anesthetics might change the way Rocuronium bromide works in the body, which could help doctors use the medication more safely and effectively in the future.
During the study, infants will receive different doses of Rocuronium bromide while undergoing surgery for craniosynostosis. Researchers will monitor how long the muscle relaxation lasts and how the medication interacts with the anesthesia. This information will help improve the safety and effectiveness of muscle relaxants in young patients. The study is designed to gather important data that could benefit future medical treatments for infants with similar conditions.



Hungary